购物车
- 全部删除
- 您的购物车当前为空
BET-IN-16 (Comp I) 是一种BET抑制剂,展现出抗癌活性。BET-IN-16抑制前列腺癌细胞的生长,其对LNCaP和22Rv1细胞的IC50值分别为0.043 μM和0.034 μM。
BET-IN-16 (Comp I) 是一种BET抑制剂,展现出抗癌活性。BET-IN-16抑制前列腺癌细胞的生长,其对LNCaP和22Rv1细胞的IC50值分别为0.043 μM和0.034 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 9,800 | 8-10周 | |
50 mg | ¥ 19,800 | 8-10周 | |
100 mg | ¥ 25,500 | 8-10周 |
产品描述 | BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells. It exhibits potent inhibitory effects with half-maximal inhibitory concentration (IC50) values of 0.043 μM for LNCaP cells and 0.034 μM for 22Rv1 cells [1]. |
分子量 | 515.56 |
分子式 | C31H25N5O3 |
CAS No. | 2089390-09-8 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容